HighTower Advisors »

Ascendis Pharma A S shares owned by HighTower Advisors

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2025-03-31 $2.8M 18k 155.86
2024-12-31 $484k 3.5k 137.67
2024-06-30 $393k 2.8k 138.72

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Vanguard Index Fds Growth Etf (VUG)

View all positions for HighTower Advisors

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
venBio Select Advisor
FMR
Henderson Group
Lombard Odier Asset Management
Artisan Partners Limited Partnership
Capital Research and Management Company - Division 3
T. Rowe Price Investment Management
Massachusetts Financial Services
Wellington Management Company
Franklin Resources
Perceptive Advisors
Invesco
Polar Capital Holdings

View all funds holding Ascendis Pharma A S